We offer a variety of integrated
services including
consultancy, study design and
research & development to the public and private sectors regarding biomarker applications principally in the hemato-oncology sectors. Our developing portfolio of IT, platform and reagent solutions to streamline, quantify and qualify both solid and liquid biopsy diagnostics specifically related to molecular genetic and molecular pathology empower our groups serviceability across all sectors. This is matched by several long standing collaborations with industry leaders in the design and validation of devices and reagents; validation, registration and α/β studies.
Our team extends across several departments: pathology, molecular genetics, IT, statistics, bioinformatics, manufacturing, regulatory and clinical in order to address point specific issues or implement holistic solutions and/or project portfolios from pre-clinical models to clinical trials and companion diagnostics.
